Epidermal growth factor receptor (EGFR) mutations account for 50–60% of driver oncogenes of lung adenocarcinomas in individuals of the East Asian ethnicity or never smokers (Shigematsu H et al. 2005). Here, EGFR is linked to lung adenocarcinoma.